InMed Pharmaceuticals (INM) Revenue Growth (3y) (2024 - 2025)
InMed Pharmaceuticals (INM) Revenue Growth (3y) (2024 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 2.84% |
| 3 | Zoetis | 32.51 Bn | 30.57 Bn | 1.62 Bn | 4.19% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -4.46% |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | 15.52% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | -2.00% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 24.66% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn | 2.94% |
| 10 | InMed Pharmaceuticals | 6.92 Mn | 1.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.41% |
| Sep 30, 2025 | 51.71% |
| Jun 30, 2025 | 36.34% |
| Mar 31, 2025 | 28.11% |
| Dec 31, 2024 | 61.26% |